Get the Stockscreener App
31.39
0.25%
-0.08
Alkermes Plc Stock (ALKS) Latest News
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 12, 2025 - GuruFocus.com
Alkermes Earnings: Critical Q4 Results and 2025 Roadmap Coming February 12 - StockTitan
FY2027 EPS Estimates for Alkermes Lifted by Leerink Partnrs - MarketBeat
Alkermes plc (NASDAQ:ALKS) Shares Acquired by Robeco Institutional Asset Management B.V. - MarketBeat
Trading (ALKS) With Integrated Risk Controls - Stock Traders Daily
Alkermes plc (NASDAQ:ALKS) EVP Sells $3,234,421.90 in Stock - MarketBeat
Alkermes plc (NASDAQ:ALKS) Sees Large Decline in Short Interest - MarketBeat
BofA Adjusts Price Target on Alkermes Public to $33 From $31 -February 03, 2025 at 10:16 am EST - Marketscreener.com
FY2025 EPS Estimates for Alkermes Lowered by Leerink Partnrs - MarketBeat
Alkermes FY2027 EPS Forecast Increased by Leerink Partnrs - Defense World
FY2025 EPS Estimates for Alkermes Reduced by Leerink Partnrs - Defense World
Alkermes plc (NASDAQ:ALKS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Jefferies maintains Buy on Alkermes stock, target at $41 By Investing.com - Investing.com UK
Pacer Advisors Inc. Decreases Stock Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes Wide Awake To Blockbuster Narcolepsy Market Potential - Citeline News & Insights
Alkermes Plc to Host Earnings Call - ACCESS Newswire
Alkermes (NASDAQ:ALKS) Trading Up 5.4%Still a Buy? - MarketBeat
(ALKS) Pivots Trading Plans and Risk Controls - Stock Traders Daily
With nearly $1B in the bank, Alkermes is on the hunt for deals - The Business Journals
Short Interest in Alkermes plc (NASDAQ:ALKS) Drops By 14.1% - MarketBeat
Benign Growth For Alkermes plc (NASDAQ:ALKS) Underpins Its Share Price - Simply Wall St
(ALKS) Proactive Strategies - Stock Traders Daily
Alkermes plc (NASDAQ:ALKS) Holdings Trimmed by JPMorgan Chase & Co. - MarketBeat
FY2024 EPS Estimates for Alkermes Lowered by Zacks Research - Defense World
Zacks Research Reduces Earnings Estimates for Alkermes - MarketBeat
What is Zacks Research's Forecast for Alkermes Q2 Earnings? - MarketBeat
Alkermes plc (NASDAQ:ALKS) Receives $36.00 Average PT from Brokerages - MarketBeat
Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Malaysian Reserve
Alkermes to Report Third Quarter Financial Results on October 24, 2024 - Quantisnow
Declining Stock and Solid Fundamentals: Is The Market Wrong About Alkermes plc (NASDAQ:ALKS)? - Yahoo Finance
Alkermes plc (NASDAQ:ALKS) Sees Large Decrease in Short Interest - MarketBeat
Principal Financial Group Inc. Has $24.57 Million Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
(ALKS) On The My Stocks Page - Stock Traders Daily
Alkermes plc (NASDAQ:ALKS) Stake Boosted by Sanctuary Advisors LLC - MarketBeat
Expansion Therapeutics Names Elliot Ehrich, MD, Chief Medical Officer - Marketscreener.com
Alkermes pays off and terminates major credit agreement By Investing.com - Investing.com Canada
2025 will be a big year for Mural Oncology's drugs in development - The Business Journals
Alkermes pays off and terminates major credit agreement - Investing.com
Alkermes Prepares for New Flexibility Post Credit Termination - TipRanks
Tidal Investments LLC Takes Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Geode Capital Management LLC Sells 60,037 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
We Think Alkermes (NASDAQ:ALKS) Can Stay On Top Of Its Debt - Simply Wall St
Wilmington Savings Fund Society FSB Invests $582,000 in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Barclays PLC Boosts Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes To Take Part In The Fourth Annual Evercore ISI Healthconx Conference - Environmental Expert
Opioid Use Disorder Market: Share, Key Trends, Growth Drivers, - openPR
When (ALKS) Moves Investors should Listen - Stock Traders Daily
0.50%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):